{"ticker": {"uuid": "f86b45f4-58ab-4ab5-8b23-dcfea090fb04", "symbol": "002772", "name": "Tianshui Zhongxing Bio-technology Co.,Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Consumer Defensive", "industry": "Farm Products"}, "articles": [{"title": "Zhongxing Biotechnology (002772.SZ): Net profit for the first half of the year is expected to increase by 160.79%", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNWll6Wlppa3g3MjdMU2xOMWZyUTFqclAxaWs4YndzY1BHSE14WVRHbV8yTy1UMW9DeTNvbWF1SEtjYWtLM2RiczFLWFpZMVNQa2FnQ3BMMGNwS0ZpNFhBMGpvX3RWYnBETmVxMGxPcmUzd2k0Q0c1b2lkamZRVEF2OV9EaEJiRkh5N3NtSmdyMTFtQUNEVmFMMTVaaHcwcGQzQUZhSUI5UQ?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T11:30:27+00:00", "published_display": "14 Jul 2026 11:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Tianshui Zhongxing Bio-Technology Co. Ltd. Class A \u2013 SZSE:002772", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOWTlCcE12REV4VlUybHhvT2dtYklRNW81Zy1SdlpkUlA0c1VqQUNxVkZnMms4bl9OdjFoekJuc3EwZUJCR01pQmJ0eTBEVjJZV04xMTVRTk9pOWw1LWpCNlpPdFZYa2QzMUtocGVnMVcyTmh0N3dNd1N4Mk4xOWRJeVZHRS1nMm94RS1CdmxoeGsxWjMtMzZfMkxRTUR3d1hZWHQ2VlY2SFNMQkRnLVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T18:56:26+00:00", "published_display": "06 Jul 2026 18:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Zhongxing Biotechnology (002772.SZ): Net profit for the first half of the year is expected to increase by 160.79%", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNWll6Wlppa3g3MjdMU2xOMWZyUTFqclAxaWs4YndzY1BHSE14WVRHbV8yTy1UMW9DeTNvbWF1SEtjYWtLM2RiczFLWFpZMVNQa2FnQ3BMMGNwS0ZpNFhBMGpvX3RWYnBETmVxMGxPcmUzd2k0Q0c1b2lkamZRVEF2OV9EaEJiRkh5N3NtSmdyMTFtQUNEVmFMMTVaaHcwcGQzQUZhSUI5UQ?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T11:30:27+00:00", "published_display": "14 Jul 2026 11:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Tianshui Zhongxing Bio-Technology Co. Ltd. Class A \u2013 SZSE:002772", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOWTlCcE12REV4VlUybHhvT2dtYklRNW81Zy1SdlpkUlA0c1VqQUNxVkZnMms4bl9OdjFoekJuc3EwZUJCR01pQmJ0eTBEVjJZV04xMTVRTk9pOWw1LWpCNlpPdFZYa2QzMUtocGVnMVcyTmh0N3dNd1N4Mk4xOWRJeVZHRS1nMm94RS1CdmxoeGsxWjMtMzZfMkxRTUR3d1hZWHQ2VlY2SFNMQkRnLVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T18:56:26+00:00", "published_display": "06 Jul 2026 18:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 53, "total_relevant": 2, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 1, "score": 59, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 58, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 10.19, "latest_week": "2026-07-17", "one_week_move": -19.9, "four_week_move": -19.2, "twelve_week_move": -41.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.864081, "market_dynamics_buy_signal": false, "relative_strength": -21.270099, "fair_value_gap": 13.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.4379, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-19.9% over one week, -19.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "\u5bcc\u9014\u725b\u725b", "count": 1}, {"label": "TradingView", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}, {"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-19.9% over one week, -19.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Zhongxing Biotechnology (002772.SZ): Net profit for the first half of the year is expected to increase by 160.79%"}], "updated_at": "2026-07-21T20:32:29.790518+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}